Nautilus Biotechnology, Inc. Quarterly Debt-to-equity in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Nautilus Biotechnology, Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q3 2024.
  • Nautilus Biotechnology, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 15.7 %, a 17% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 15.7 +2.28 +17% Sep 30, 2024
Q2 2024 15.4 +3.02 +24.5% Jun 30, 2024
Q1 2024 14.9 +3.58 +31.6% Mar 31, 2024
Q4 2023 14.5 +4.07 +39.1% Dec 31, 2023
Q3 2023 13.5 +3.42 +34.1% Sep 30, 2023
Q2 2023 12.4 +4.55 +58.3% Jun 30, 2023
Q1 2023 11.4 +5.91 +109% Mar 31, 2023
Q4 2022 10.4 +5.6 +116% Dec 31, 2022
Q3 2022 10 +6.59 +192% Sep 30, 2022
Q2 2022 7.8 +0.46 +6.27% Jun 30, 2022
Q1 2022 5.44 Mar 31, 2022
Q4 2021 4.81 Dec 31, 2021
Q3 2021 3.43 Sep 30, 2021
Q2 2021 7.34 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.